Skip to main content
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

Fig. 2

Survival function according to CVP status. a Unadjusted analysis—median overall survival estimates were not reached in the convalescent plasma (CVP) group and 1.3 month in the non-convalescent plasma (non-CVP) group; 30-day survival estimates were 69% in the CVP group and 54% in the non-CVP group. Statistical significance calculated using the log rank test. A p value < 0.05 was considered statistically significant. b IPTW-weighted analysis—median overall survival estimates were not reached in the convalescent plasma (CVP) group and 1.3 month in the non-convalescent plasma (non-CVP) group; 30-day survival estimates were 77% in the CVP group and 59% in the non-CVP group. Statistical significance calculated using the log rank test. A p value < 0.05 was considered statistically significant

Back to article page